Indeed, IGF-1 treatment increases ERK and AKT phosphorylation in the GC cell line BGC823, and the expression of survivin and EMT biomarkers, including N-cadherin, MMP2, and SNAIL [207]. This evidence concerns the gene AKT1 and gastric cancer.